1. Home
  2. AMRX vs PBH Comparison

AMRX vs PBH Comparison

Compare AMRX & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • PBH
  • Stock Information
  • Founded
  • AMRX 2002
  • PBH 1996
  • Country
  • AMRX United States
  • PBH United States
  • Employees
  • AMRX N/A
  • PBH N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • PBH Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMRX Health Care
  • PBH Health Care
  • Exchange
  • AMRX Nasdaq
  • PBH Nasdaq
  • Market Cap
  • AMRX 2.9B
  • PBH 3.3B
  • IPO Year
  • AMRX N/A
  • PBH 2005
  • Fundamental
  • Price
  • AMRX $9.81
  • PBH $64.10
  • Analyst Decision
  • AMRX Strong Buy
  • PBH Buy
  • Analyst Count
  • AMRX 4
  • PBH 5
  • Target Price
  • AMRX $12.00
  • PBH $94.00
  • AVG Volume (30 Days)
  • AMRX 1.5M
  • PBH 577.8K
  • Earning Date
  • AMRX 11-07-2025
  • PBH 11-06-2025
  • Dividend Yield
  • AMRX N/A
  • PBH N/A
  • EPS Growth
  • AMRX N/A
  • PBH 4.18
  • EPS
  • AMRX 0.01
  • PBH 4.26
  • Revenue
  • AMRX $2,852,914,000.00
  • PBH $1,120,150,000.00
  • Revenue This Year
  • AMRX $9.56
  • PBH N/A
  • Revenue Next Year
  • AMRX $6.27
  • PBH $2.24
  • P/E Ratio
  • AMRX $903.77
  • PBH $15.28
  • Revenue Growth
  • AMRX 9.81
  • PBH 0.63
  • 52 Week Low
  • AMRX $6.69
  • PBH $61.93
  • 52 Week High
  • AMRX $10.34
  • PBH $90.04
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 60.91
  • PBH 38.27
  • Support Level
  • AMRX $9.57
  • PBH $61.93
  • Resistance Level
  • AMRX $10.34
  • PBH $66.04
  • Average True Range (ATR)
  • AMRX 0.25
  • PBH 1.46
  • MACD
  • AMRX -0.04
  • PBH 0.09
  • Stochastic Oscillator
  • AMRX 48.04
  • PBH 32.44

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Share on Social Networks: